Leukemia

Myeloid and Monocytic LeukemiaPhase II Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma
Myeloid and Monocytic LeukemiaA Randomized Phase II Study of Venetoclax and HMA-Based Therapies for the Treatment of Older and Unfit Adults With Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML): A MyeloMATCH Treatment Trial
Myeloid and Monocytic LeukemiaMYELOMATCH: A Screening Study to Assign People with Myeloid Cancer to a Treatment Study or Standard of Care Treatment within myeloMATCH (MyeloMATCH Screening Trial)
Myeloid and Monocytic LeukemiaA Multi-phase, Dose-Escalation Followed by an Open-label, Randomized, Crossover Study of Oral ASTX030 (Cedazuridine and Azacitidine Given in Combination) Versus Subcutaneous Azacitidine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)
Leukemia, not otherwise specified, Leukemia, other, Myeloid and Monocytic Leukemia, Other HematopoieticVenetoclax in Combination with ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndromes/Myeloproliferative Neoplasms